Share Email Print
cover

Proceedings Paper

Use of chloro-aluminum sulfonated phthalocyanine as a photosensitizer in the treatment of malignant tumors in dogs and cats
Author(s): George M. Peavy; Mary Kay Klein; H. Carlton Newman; Walter Gregory Roberts; Michael W. Berns
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Chloro-aluminum sulfonated phthalocyanine (CASPc) has been proposed as a photosensitizing agent for photodynamic therapy (PDT) of neoplasia. This paper reviews the results of PDT treatment using CASPc as a photosensitizing agent in the treatment of 15 cats representing 23 sites of facial, solar induced squamous cell carcinoma, 4 dogs with hemangiopericytomas, 3 dogs with fibrosarcomas, and 1 dog with multiple cutaneous mast cell tumors. The results of this study to date suggest that CASPc is a good photosensitizing agent for the treatment of some forms of spontaneously occurring malignant neoplasia and should be more thoroughly evaluated for this purpose.

Paper Details

Date Published: 1 May 1991
PDF: 8 pages
Proc. SPIE 1424, Lasers in Orthopedic, Dental, and Veterinary Medicine, (1 May 1991); doi: 10.1117/12.44004
Show Author Affiliations
George M. Peavy, Beckman Laser Institute and Medical Clinic, Univ. of Californai/Irvine (United States)
Mary Kay Klein, Beckman Laser Institute and Medical Clinic, Univ. of Californai/Irvine (United States)
H. Carlton Newman, Beckman Laser Institute and Medical Clinic, Univ. of Californai/Irvine (United States)
Walter Gregory Roberts, Beckman Laser Institute and Medical Clinic, Univ. of Californai/Irvine (United States)
Michael W. Berns, Beckman Laser Institute and Medical Clinic, Univ. of Californai/Irvine (United States)


Published in SPIE Proceedings Vol. 1424:
Lasers in Orthopedic, Dental, and Veterinary Medicine
Stephen J. O'Brien; Douglas N. Dederich; Harvey Wigdor; Ava Micky Trent, Editor(s)

© SPIE. Terms of Use
Back to Top